Delivery Order SPE2DB20D3103-SPE2DB25FL6J1
Award Date
11/13/24
Potential Completion Date
11/14/24
Potential Value
$10K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order valued at $1,525.16 with a firm fixed price pricing type. The contract is for the supply of DAPAGLIFLOZIN 10 MG TABLET 30S, a pharmaceutical product, with a performance period extending through June 13, 2025. The contract does not have a set-aside designation, indicating...
This federal contract award, valued at $2,518.66, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order to supply 4566964347 DAPAGLIFLOZIN 10 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of January 17, 2025 and is a firm fixed-price contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award, valued at $1,377.36, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4568648668 - DAPAGLIFLOZIN 5 MG TABLET 30S, a medication used to treat diabetes. The contract has an ultimate completion date of June 27, 2025 and is a firm fixed-price delivery order. This award is not designated as a set-aside contract. Amerisourcebergen Drug...
This federal contract award, valued at $7,063.53, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DAPAGLIFLOZIN 10 MG TABLET 30S, a pharmaceutical product, with a performance period extending to February 25, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical,...
This federal contract award, valued at $2,888.90, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4566628126 ! DAPAGLIFLOZIN 10 MG TABLET 30S, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an Ultimate Completion Date of December 6, 2024. It is not designated with a set-aside requirement, indicating...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,811.35, is for the delivery of 4566263318 - DAPAGLIFLOZIN 10 MG TABLET 30S, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of October 30, 2024. This contract award is not associated with a set-aside designation, indicating open...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,527.57 firm fixed price delivery order is for the supply of 4567580884 - DAPAGLIFLOZIN 5 MG TABLET 30S. This contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $11,731.88 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of DAPAGLIFLOZIN 10 MG TABLET 30S. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical...
This federal contract award, valued at $3,507.52, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order for DAPAGLIFLOZIN 10 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of June 30, 2025 and is not set aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $2,318.69, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of 4566615603 DAPAGLIFLOZIN 10 MG TABLET 30S, a pharmaceutical product, with a completion date of December 5, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...